by Stacey Johnson | Feb 23, 2024
As a fair-skinned, freckled person (my mom says she painted them on me while I slept), and one who has a family history of skin cancers and melanoma, the news on February 19 that Iovance Biotherapeutics’ AMTAGVITM received U.S. Food and Drug Administration (FDA)...
by Stacey Johnson | Feb 16, 2024
It’s February 16. We are just over halfway through Black History Month. If you consume media and social media, this event will be top of mind right now. Thinking about Black History Month made me wonder whether Signals has a lot of content on the topic of Black...
by Stacey Johnson | Feb 2, 2024
If you have finally recovered from Advanced Therapies Week (ATW) 2024, don’t get too comfortable since the website for ATW 2025, to be held in San Diego, California, is already published. It’s worth visiting as it features some nice photos of this year’s event to...
by Stacey Johnson | Jan 26, 2024
When does Mardi Gras come to Miami, Florida? When it’s Advanced Therapies Week (ATW). The industry-focused conference was back at the Miami Convention Centre in South Beach, but possibly for the last time as the conference is moving to San Diego next year. That may...
by Stacey Johnson | Jan 5, 2024
If you only read one post for 2023, please make it this one. Below are the 10 most popular posts from last year, as determined by views recorded on the website. These are not my favourite posts, although I like all of them; this ranking is completely unbiased and...
by Stacey Johnson | Dec 29, 2023
It’s been a busy year in the cell and gene therapy community and the bloggers at Signals have enjoyed putting the spotlight on news (HeLa settlement and UK rejoins Horizon Europe), scientific advances (improving treatment for hematological malignancies and a new...
Comments